LSL Pharma Group (TSXV:LSL) Change In Receivables : C$-0.63 Mil (TTM As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group Change In Receivables?

LSL Pharma Group's change in receivables for the quarter that ended in Sep. 2024 was C$-0.13 Mil. It means LSL Pharma Group's Accounts Receivable increased by C$0.13 Mil from Jun. 2024 to Sep. 2024 .

LSL Pharma Group's change in receivables for the fiscal year that ended in Dec. 2023 was C$0.00 Mil. It means LSL Pharma Group's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

LSL Pharma Group's Accounts Receivable for the quarter that ended in Sep. 2024 was C$3.39 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. LSL Pharma Group's Days Sales Outstanding for the three months ended in Sep. 2024 was 77.23.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. LSL Pharma Group's liquidation value for the three months ended in Sep. 2024 was C$-12.07 Mil.

LSL Pharma Group Change In Receivables Historical Data

The historical data trend for LSL Pharma Group's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group Change In Receivables Chart

LSL Pharma Group Annual Data

Trend

Sep20

Dec21

Dec22

Dec23

Change In Receivables

-0.36

0.97

LSL Pharma Group Quarterly Data
	Sep20	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial										-0.25	-	-0.73	0.22	-0.13

LSL Pharma Group Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.63 Mil.

LSL Pharma Group (TSXV:LSL) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

LSL Pharma Group's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	3.393	/	4.009	*	91
=	77.23

2. In Ben Graham's calculation of liquidation value, LSL Pharma Group's accounts receivable are only considered to be worth 75% of book value:

LSL Pharma Group's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.164	-	17.587	+	0.75 * 3.393	+	0.5 * 5.625
=	-12.07

LSL Pharma Group Change In Receivables Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

LSL Pharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

540 d’Avaugour Street, Suite 1800, Boucherville, QC, CAN, J4B 0G6

Website

https://www.laboratoirelsl.com

LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group Headlines

No Headlines